Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34284156)
Watch
English
Matching targets for selective cancer therapy
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
title
Matching targets for selective cancer therapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
author
Mikhail Blagosklonny
series ordinal
1
object named as
Mikhail V Blagosklonny
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
publication date
1 December 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
published in
Drug Discovery Today
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
volume
8
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
issue
24
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
page(s)
1104-1107
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
cites work
Perspectives on the development of a molecularly targeted agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improving the evaluation of new cancer treatments: challenges and opportunities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Why Iressa failed: toward novel use of kinase inhibitors (outlook).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Integrating genetic approaches into the discovery of anticancer drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Choosing anticancer drug targets in the postgenomic era.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic exploitation of checkpoint defects in cancer cells lacking p53 function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Codominant interference, antieffectors, and multitarget drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective killing of transformed baby hamster kidney (BHK) cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclotherapy: protection of normal cells and unshielding of cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel (taxol)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new science-business paradigm in anticancer drug development.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
More Than One Road to Kill Tumor Cells: Why Are They Not Always Successful?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apoptosis-based therapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Apoptosis-targeted therapies for cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Requirement for p53 and p21 to sustain G2 arrest after DNA damage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1359-6446(03)02806-X
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
PubMed ID
14678733
1 reference
stated in
Europe PubMed Central
PubMed ID
14678733
retrieved
1 August 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
